@article{article, title  = {{Effect of Empagliflozin on Kidney Biochemical and Imaging Outcomes in Patients with Type 2 Diabetes, or Prediabetes, and Heart Failure with Reduced Ejection Fraction (SUGAR-DM-HF)}},

 publisher = {{Ovid Technologies (Wolters Kluwer Health)}},

 url = {{https://doi.org/10.1681/asn.20213210s1b12a }},

 year = {{2021}},

 month = {{10}},

 author = {{Lee MM and Allwood-Spiers S and Barrientos PH and Wetherall K and Mcconnachie A and Welsh P and Roditi G and Sourbron S and Radjenovic A and McMurray J and Jhund P et al}},

 doi = {{10.1681/asn.20213210s1b12a}},

 volume = {{32}},

 journal = {{Journal of the American Society of Nephrology}},

 issue = {{10S}},

 pages = {{B12-B12}},

 note = {{Accessed on 2025/12/05}}}